We took note of two recent POLITICO articles that make very, very clear the reality of what’s going…
Rhetoric in Washington, DC around high and rising drug prices continues to intensify. As Congress considers potential legislation,…
Although Congress has devoted much attention to exploring pharmaceutical manufacturers and pharmacy benefit managers, less attention has been…
As Congress returns for a new work period, both parties are renewing their focus on how to bring…
Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat…
Americans have overwhelmingly supported action by Congress to lower Big Pharma’s drug prices for years, and now –…
The Biden Administration should work with Congress and act now to eliminate the Rebate Rule, stop damaging Medicare…
On October 1, Matrix Global Advisors’ CEO Alex Brill joined POLITICO health care contributor and podcast host Carol…
It’s widely agreed that Medicare Part D is one of the most successful public-private partnerships, delivering affordability and…
Product hopping is a practice commonly used by pharmaceutical companies to extend the life of their patents, and…
